24/7 Patient Assistance: 760-405-8205

Jonathan Dowell, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Lung Cancer

specialties & services

  • Bio & Insurance Information

    Dr. Jonathan Dowell graduated medical school from University of Chicago Pritzker School of Medicine and after that, he completed his residency program at VA Medical Center. A fellowship in hematology/oncology followed at Vanderbilt University. Dr. Dowell is now specialized in hematology and board certified in internal medicine, medical oncology, and hematology. He has been practicing medicine for more than 20 years and is affiliated with the UT Southwestern Medical Center. During his career, he was in charge of several clinical trials and had also published multiple writings of medical interest in collaboration with other doctors.

  • Education & Training


    University of Chicago Pritzker School of Medicine Graduated in 1993

    Medical School


    Vanderbilt University Med Center



    Vanderbilt University


  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    University of Texas Southwestern Medical Center

    Languages: English/Spanish

    (214) 648-3111

    5323 Harry Hines Blvd

    Dallas, Texas 75390

    Read More

    Veterans Affairs North Texas Health Care System Dallas

    Languages: English/Spanish

    (214) 742-8387

    4500 S Lancaster Rd

    Dallas, Texas 75216

    Read More
  • Publications & Memberships

    Dr. Jonathan Dowell has contributed to 3 publications.

    A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma

    Dowell JE1, Dunphy FR, Taub RN, Gerber DE, Ngov L, Yan J, Xie Y, Kindler HL

    See more >>

    Consent timing and experience: modifiable factors that may influence interest in clinical research

    Gerber DE1, Rasco DW, Skinner CS, Dowell JE, Yan J, Sayne JR, Xie Y

    See more >>

    ERCC1 expression and outcomes in head and neck cancer treated with concurrent cisplatin and radiation

    Hayes M1, Lan C, Yan J, Xie Y, Gray T, Amirkhan RH, Dowell JE

    See more >>


    American Society of Clinical Oncology

    American Society of Hematology